Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Identify which Dividend Etf has the smallest fee and compare leading contenders. Discover the best value funds and optimize your costs now.
27,455 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
As tax day approaches, millions await refunds. This guide on refund tracker explained: what to know outlines timing, ...
GameStop is weighing a bold move: acquiring eBay. This article breaks down whether does Gamestop's proposed acquisiti...
Chinese automakers are shifting from passenger cars to commercial fleets, challenging Ford's margins and strategy. Th...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
Pi Network announces a major creator-focused update that blends AI with human input, enabling non-technical users to ...
Ken Griffin, the Citadel founder once openly skeptical of AI, has pivoted to embracing its potential, telling audienc...
OpenAI is moving toward a potential trillion-dollar IPO, with confidential SEC filings reportedly underway and a Sept...
A broad rally in memory stocks follows a strong Micron session, lifting SanDisk and Western Digital as AI datacenter ...
Longbridge Financial and Friday Harbor unveiled a joint AI pre-underwriting platform designed to flag issues early in...
Salesforce stock has faced renewed pressure as growth slows and concerns about AI monetization persist. This pragmati...
Meta Platforms is betting big on AI and cloud tech, fueling debate over whether meta's spending spree reckless moves ...